ModelEdge
Tonix Pharmaceuticals Holding Corp
TNXP
Filing type
10-K
Filing date
Mar 17, 2025
Updated
Mar 18, 2025 ยท 2:42 PM

Filing

10-KFY 2024

Exhibits

EX-4.06DESCRIPTION OF REGISTRANT'S SECURITIESEX-10.56BASE AGREEMENT BETWEEN ADVANCED TECHNOLOGY INTERNATIONAL AND TONIX PHARMACEUTICALS, INC.EX-10.57PROJECT AGREEMENT NO. 1 BY AND BETWEEN ADVANCED TECHNOLOGY INTERNATIONAL AND TONIX PHARMACEUTICALS, INC.EX-19.01TONIX PHARMACEUTICALS HOLDING CORP. INSIDER TRADING POLICYEX-21.01LIST OF SUBSIDIARIESEX-23.01CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMEX-31.01CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302EX-31.02CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302EX-32.01CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906EX-97.01TONIX PHARMACEUTICALS HOLDING CORP. COMPENSATION RECOVERY POLICYGRAPHICGraphic